Necitumumab
Necitumumab is a human IgG monoclonal antibody directed against EGFR. Necitumumab can be used for research of NSCLC, colorectal cancer, etc[1].
Product Specifications
CAS Number
[906805-06-9]
Product Name Alternative
11F8; IMC-11F8; LY3012211
UNSPSC
12352203
Target
EGFR
Type
Inhibitory Antibodies
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/necitumumab.html
Purity
99.9
Solubility
10 mM in DMSO|H2O
Smiles
[Necitumumab]
Molecular Weight
(144.78 kDa)
References & Citations
[1]Garnock-Jones KP. Necitumumab: First Global Approval. Drugs. 2016 Feb;76 (2) :283-9.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
495488 100 µL
VTI1A (Vesicle Transport Through Interaction with t-SNAREs Homolog 1A, Vesicle Transport Through interaction with t-SNAREs Homolog 1A (Yeast) )
Ask
View Details 
